vs
Side-by-side financial comparison of Angel Oak Mortgage REIT, Inc. (AOMR) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Angel Oak Mortgage REIT, Inc. is the larger business by last-quarter revenue ($10.9M vs $9.2M, roughly 1.2× Foghorn Therapeutics Inc.). Angel Oak Mortgage REIT, Inc. runs the higher net margin — 103.9% vs -234.3%, a 338.2% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 10.4%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 12.7%).
Angel Oak Mortgage REIT, Inc. is a U.S.-based real estate investment trust focused on investing in residential mortgage assets, including non-agency mortgage-backed securities, residential mortgage loans, and credit-linked real estate instruments. It serves U.S. institutional and retail investors, targeting competitive risk-adjusted returns through regular income and long-term capital growth.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
AOMR vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.9M | $9.2M |
| Net Profit | $11.3M | $-21.7M |
| Gross Margin | — | — |
| Operating Margin | — | -258.2% |
| Net Margin | 103.9% | -234.3% |
| Revenue YoY | 10.4% | 223.8% |
| Net Profit YoY | 175.2% | -11.1% |
| EPS (diluted) | $0.44 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.9M | $9.2M | ||
| Q3 25 | $10.2M | $8.2M | ||
| Q2 25 | $9.9M | $7.6M | ||
| Q1 25 | $10.1M | $6.0M | ||
| Q4 24 | $9.9M | $2.9M | ||
| Q3 24 | $9.0M | $7.8M | ||
| Q2 24 | $9.5M | $6.9M | ||
| Q1 24 | $8.6M | $5.0M |
| Q4 25 | $11.3M | $-21.7M | ||
| Q3 25 | $11.4M | $-15.8M | ||
| Q2 25 | $767.0K | $-17.9M | ||
| Q1 25 | $20.5M | $-18.8M | ||
| Q4 24 | $-15.1M | $-19.5M | ||
| Q3 24 | $31.2M | $-19.1M | ||
| Q2 24 | $-273.0K | $-23.0M | ||
| Q1 24 | $12.9M | $-25.0M |
| Q4 25 | — | -258.2% | ||
| Q3 25 | — | -226.9% | ||
| Q2 25 | 7.7% | -279.2% | ||
| Q1 25 | — | -385.0% | ||
| Q4 24 | -152.6% | -840.5% | ||
| Q3 24 | — | -305.5% | ||
| Q2 24 | -1.4% | -386.6% | ||
| Q1 24 | — | -558.3% |
| Q4 25 | 103.9% | -234.3% | ||
| Q3 25 | 112.1% | -194.4% | ||
| Q2 25 | 7.7% | -237.3% | ||
| Q1 25 | 203.5% | -316.4% | ||
| Q4 24 | -152.6% | -682.9% | ||
| Q3 24 | 345.9% | -244.9% | ||
| Q2 24 | -2.9% | -333.6% | ||
| Q1 24 | 150.1% | -495.4% |
| Q4 25 | $0.44 | $-0.35 | ||
| Q3 25 | $0.46 | $-0.25 | ||
| Q2 25 | $0.03 | $-0.28 | ||
| Q1 25 | $0.87 | $-0.30 | ||
| Q4 24 | $-0.62 | $-0.23 | ||
| Q3 24 | $1.29 | $-0.31 | ||
| Q2 24 | $-0.01 | $-0.45 | ||
| Q1 24 | $0.51 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.6M | $80.9M |
| Total DebtLower is stronger | $2.3B | — |
| Stockholders' EquityBook value | $267.5M | $-108.5M |
| Total Assets | $2.7B | $198.1M |
| Debt / EquityLower = less leverage | 8.51× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.6M | $80.9M | ||
| Q3 25 | $51.6M | $89.3M | ||
| Q2 25 | $40.5M | $72.6M | ||
| Q1 25 | $38.7M | $61.0M | ||
| Q4 24 | $40.8M | $55.5M | ||
| Q3 24 | $42.1M | $57.7M | ||
| Q2 24 | $44.0M | $138.9M | ||
| Q1 24 | $39.4M | $79.3M |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $267.5M | $-108.5M | ||
| Q3 25 | $264.2M | $-89.7M | ||
| Q2 25 | $246.4M | $-76.7M | ||
| Q1 25 | $251.5M | $-61.7M | ||
| Q4 24 | $239.0M | $-45.5M | ||
| Q3 24 | $265.1M | $-28.3M | ||
| Q2 24 | $255.8M | $-14.3M | ||
| Q1 24 | $263.3M | $-97.5M |
| Q4 25 | $2.7B | $198.1M | ||
| Q3 25 | $2.6B | $205.0M | ||
| Q2 25 | $2.6B | $226.2M | ||
| Q1 25 | $2.7B | $258.7M | ||
| Q4 24 | $2.3B | $284.0M | ||
| Q3 24 | $2.3B | $308.4M | ||
| Q2 24 | $2.1B | $328.6M | ||
| Q1 24 | $2.3B | $255.0M |
| Q4 25 | 8.51× | — | ||
| Q3 25 | 8.37× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-407.0M | $-22.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -35.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-407.0M | $-22.3M | ||
| Q3 25 | $-173.4M | $-18.9M | ||
| Q2 25 | $20.6M | $-21.0M | ||
| Q1 25 | $-201.7M | $-24.0M | ||
| Q4 24 | $-221.5M | $-24.5M | ||
| Q3 24 | $-212.4M | $-21.0M | ||
| Q2 24 | $-24.2M | $-25.5M | ||
| Q1 24 | $40.2M | $-29.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | -35.96× | — | ||
| Q3 25 | -15.19× | — | ||
| Q2 25 | 26.92× | — | ||
| Q1 25 | -9.83× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AOMR
| Nonrelated Party | $6.4M | 59% |
| Other | $4.5M | 41% |
FHTX
Segment breakdown not available.
